COLLABORATION AND LICENSE AGREEMENTCollaboration and License Agreement • March 22nd, 2021 • Acer Therapeutics Inc. • Pharmaceutical preparations • New York
This Collaboration and License Agreement (the “Agreement”) is entered into on March 19, 2021 (the “Effective Date”) between Acer Therapeutics Inc., a Delaware corporation, with its principal place of business at 300 Washington Street, Suite 351, Newton, MA, USA (“Acer”), and Relief Therapeutics Holding AG, a company organized and existing under the laws of Switzerland and having its registered address at Avenue de Secheron 15, 1202 Geneve, Switzerland (“Relief”). Relief and Acer are sometimes referred to herein individually as a “Party” and collectively as the “Parties.”
